San Francisco, CA, United States of America

Richard Hung Chiu Yu

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Hung Chiu Yu. Retrieved from https://idiyas.com/inventor/richard-hung-chiu-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Richard Hung Chiu Yu

Introduction: Richard Hung Chiu Yu is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Richard Hung Chiu Yu holds several patents in the fields of technology and healthcare, showcasing his continuous innovation and dedication to improving lives.

Career Highlights: With a career spanning over two decades, Richard Hung Chiu Yu has worked with leading companies to develop cutting-edge solutions, earning him a reputation as a visionary in the world of inventions.

Collaborations: Throughout his career, Richard Hung Chiu Yu has collaborated with top researchers, engineers, and scientists, fostering a culture of creativity and excellence in all his projects.

Conclusion: Richard Hung Chiu Yu's passion for innovation and his relentless pursuit of excellence have solidified his position as a pioneering inventor, shaping the future of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…